Deep-pocketed investors have adopted a bullish approach towards Cigna CI, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 23 extraordinary options activities for Cigna. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 56% leaning bullish and 39% bearish. Among these notable options, 9 are puts, totaling $719,910, and 14 are calls, amounting to $966,650.
Expected Price Movements
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $250.0 to $450.0 for Cigna over the recent three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Cigna options trades today is 539.43 with a total volume of 1,398.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Cigna's big money trades within a strike price range of $250.0 to $450.0 over the last 30 days.
Cigna Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CI | PUT | TRADE | BULLISH | 01/16/26 | $35.4 | $32.5 | $32.5 | $280.00 | $325.0K | 2.7K | 103 |
| CI | CALL | TRADE | BULLISH | 06/20/25 | $22.3 | $21.1 | $21.9 | $270.00 | $219.0K | 14 | 112 |
| CI | PUT | TRADE | BULLISH | 01/16/26 | $34.9 | $32.1 | $32.5 | $280.00 | $162.5K | 2.7K | 153 |
| CI | CALL | TRADE | BULLISH | 03/21/25 | $10.8 | $10.0 | $10.6 | $280.00 | $159.0K | 3 | 153 |
| CI | CALL | SWEEP | NEUTRAL | 01/16/26 | $51.9 | $47.9 | $49.62 | $250.00 | $124.2K | 69 | 27 |
About Cigna
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
After a thorough review of the options trading surrounding Cigna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Cigna's Current Market Status
- Trading volume stands at 858,954, with CI's price down by -9.35%, positioned at $274.95.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 0 days.
What Analysts Are Saying About Cigna
In the last month, 1 experts released ratings on this stock with an average target price of $390.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Cigna with a target price of $390.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cigna options trades with real-time alerts from Benzinga Pro.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
